Tms Co., Ltd. (4891) Press Release
Notice of Submission of a Clinical Trial Plan Notification for a Phase IIa Clinical Trial of TMS-008 for Acute Kidney Injury
Filed with TSE ·
6ix hasn’t read this filing yet.
Earlier from Tms
- (Correction) Notice of Partial Correction to “Presentation Materials”
- Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]
- Mindful Health Solutions Advances Patient Experience with Sohar Health's Verification Solution